Hansa Biopharma (previously known as Hansa Medical) is a biopharmaceutical company developing immunomodulating therapies. It offers an enzyme technology platform that helps to develop immunomodulatory treatments for rare immunoglobulin G (IgG)-mediated autoimmune conditions, transplant rejection, and cancer.
|Employees (est.) (Dec 2019)||74|
When was Hansa Biopharma founded?
Hansa Biopharma was founded in 2007.
How many employees does Hansa Biopharma have?
Hansa Biopharma has 74 employees.
Who are Hansa Biopharma competitors?
Competitors of Hansa Biopharma include ReNetX Bio, Entrada Therapeutics and Navega Therapeutics.
Receive alerts for 300+ data fields across thousands of companies